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Abstract
Background: Early review of antimicrobial prescribing decisions within 48 h is recommended to reduce the overall
use of unnecessary antibiotics, and in particular the use of broad-spectrum antibiotics. When parenteral antibiotics
are used, blood culture results provide valuable information to help decide whether to continue, alter or stop
antibiotics at 48 h. The objective of this study was to investigate the frequency of parenteral antibiotic use, broad
spectrum antibiotic use and use of blood cultures when parenteral antibiotics are initiated in patients admitted via
the Emergency Department.
Methods: We used electronic health records from patients admitted from the Emergency Department at University
Hospital Birmingham in 2014.
Results: Six percent (4562/72939) of patients attending the Emergency department and one-fifth (4357/19034) of
those patients admitted to hospital were prescribed a parenteral antimicrobial. More than half of parenteral
antibiotics used were either co-amoxiclav or piperacillin-tazobactam. Blood cultures were obtained in less than
one-third of patients who were treated with a parenteral antibiotic.
Conclusions: Parenteral antibiotics are frequently used in those admitted from the Emergency Department; they
are usually broad spectrum and are usually initiated without first obtaining cultures. Blood cultures may have
limited value to support prescribing review as part of antimicrobial stewardship initiatives.
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Background
Growing concern about the clinical and economic im-
pact of antimicrobial resistance has led to a major focus
on antimicrobial stewardship to reduce inappropriate
antibiotic prescribing..
Suboptimal antimicrobial prescribing is likely to be
common in the Emergency Department (ED) [1], where
junior clinicians are under pressure to initiate antibiotics
promptly in patients who are unwell [2], time is con-
strained and there are large numbers of prescribers with
rapid staff turnover [3]. Most patients in hospital are
admitted via the ED, so prescribing in the ED sets up
the patterns of antimicrobial use across the hospital. Yet
the ED has not been the focus of antimicrobial steward-
ship initiatives [4], partly because those who prescribe in
the ED are rarely responsible for reviewing their pre-
scribing decisions.
The clinical decision to revise antimicrobial therapy is
strongly linked to the availability of a microbiological diag-
nosis. But, in many patients with suspected bacterial infec-
tion specimens are not submitted for microbiological
testing. Recent data from Acute Trusts suggests that fewer
than half of antibiotic prescriptions are reviewed within 48
h [5]. We used electronic health records (EHRs) to investi-
gate the extent to which blood cultures are used when
parenteral antibiotics are initiated in secondary care using
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data from University Hospitals Birmingham NHS Founda-
tion Trust (UHB), the largest single-site hospital in
England.
Methods
We included data from UHB, a unique data holding which
covers adult patient attendances at Queen Elizabeth
Hospital Birmingham (QEHB). QEHB provides direct
clinical services to nearly 800,000 adult patients per year
and is a regional centre for specialist services including
liver transplantation and renal dialysis. The local popula-
tion is comparatively young and ethnically diverse, and in-
cludes patients with high levels of social deprivation. UHB
captures large amounts of data from its patients in a num-
ber of different systems electronically, which can be linked
together to evaluate patient status and clinical outcomes
including information on diagnoses, treatments, investiga-
tions, test results and prescriptions.
To calculate the prevalence of parenteral antimicrobial
use and blood culture sampling amongst patients attend-
ing the ED, and to investigate the clinical and microbio-
logical outcomes for those patients who were admitted,
we extracted the most recent year of data for a cohort of
patients who attended the ED in 2014. We defined blood
culture sampling as an electronic request for a blood
culture recorded within 48 h following attendance at the
ED. Use of parenteral antibiotics was defined as a pre-
scription for a parenteral antibiotic within 48 h of ED at-
tendance. This 48 h time period was chosen because
blood cultures requested overnight may not be regis-
tered on the database until the following morning, po-
tentially underestimating the frequency of blood culture
use in this setting. The admission diagnosis was derived
from the primary ICD-code for the whole admission.
Results
In 2014, 72939 patients were seen in the ED at QEHB,
representing 106,119 attendances, Fig. 1. At least one
parenteral antimicrobial was prescribed for 4562 (6.3 %)
of these patients within the following 48 h, most of
whom did not have a blood culture taken (3347/4562;
73.3 %). 1300 patients had a blood culture taken but
were not prescribed an antimicrobial over the same time
period.
Amongst 19034 patients who were admitted to hos-
pital from the ED, 4357 (22.9 %) received a parenteral
antimicrobial within the first 48 h and 2365 patients
(12.4 %) had a specimen taken for blood culture, Fig. 1.
An organism was identified in 11.9 % (282/2365) of pa-
tients with a blood culture, with E. coli (78/282) and S.
aureus (21/282) as the leading causes of bacteraemia,
Table 1. Overall the use of blood cultures and parenteral
antibiotics was more frequent in men compared to
women and increased from age 30 years and above,
rising sharply in the elderly, from age 60 years in men
and age 70 years in women. At all ages the use of paren-
teral antibiotics far exceeded the use of blood cultures,
Fig. 2.
Data on diagnosis was available for 1200 patients who
had both a blood culture taken and were prescribed a
parenteral antibiotic within 48 h following emergency
admission to hospital. Pneumonia was the most com-
mon diagnosis amongst this patient group (18.6 %),
followed by urinary tract infection (8.6 %), an exacerba-
tion of COPD (7.7 %), skin and soft tissue infection
(5.6 %) and sepsis (6.1 %). For at least 456 (38 %) of this
group an infection-related diagnosis was not recorded as
the primary reason for admission.
Data on the type of antimicrobial were available for
4474 patients prescribed a parenteral antibiotic within
the 48 h following emergency admission to hospital. Co-
amoxiclav was most the most commonly prescribed
antibiotic (29.9 %), followed by piperacillin-tazobactam
(20.0 %), flucloxacillin (16.0 %), clarithromycin (8.2 %)
and meropenem, which was prescribed to one in twenty
patients.
Discussion
In this study using real-world data from the largest sin-
gle site hospital in England, parenteral antimicrobials
were prescribed to six percent of patients attending the
ED and 23 % of patients admitted to hospital. Blood cul-
tures were obtained from less than one-third of patients
who were treated with parenteral antimicrobials at emer-
gency admission to hospital and a micro-organism was
identified in just 12 % of patients who had a blood cul-
ture. More than half of all patients prescribed a paren-
teral antimicrobial were treated with the broad spectrum
antibiotics co-amoxiclav or piperacillin-tazobactam.
Although the rate of pathogen detection by blood cul-
ture was low in our study, it is comparable to other studies
conducted in the ED [6, 7]. There are many factors that
can reduce the sensitivity of blood cultures such as collec-
tion of a low volume sample, poor sampling technique
and prior treatment with antimicrobials, and a further
problem is the rate of false positive tests through blood
culture contamination [8]. We were unable to determine
the proportion of blood cultures that were obtained after
antimicrobial treatment had commenced.
A key recommendation in antimicrobial stewardship
guidance is to obtain microbial cultures before starting
antibiotic treatment, provided it does not delay treatment
for patients with sepsis or severe infection [9]. National
guidance recommends that blood cultures are obtained
from all patients with moderate to severe community on-
set pneumonia [10], the major cause of infection in our
cohort. Guidance on the use of blood cultures in patients
presenting with urinary tract infection or skin and soft
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tissue disease is less clear, but there is consensus that
blood cultures should be obtained from patients with sus-
pected sepsis [11].
Our research suggests blood cultures are obtained from
less than one-third of patients who are initiated on paren-
teral antibiotics at admission to hospital. For a subset of
patients without a blood culture, specimens are likely to
have been obtained from the site of local infection (urine,
wound swabs, sputum). Nonetheless there will be a sub-
stantial proportion of patients who are treated with paren-
teral antibiotics for whom is no microbiological specimen
diagnosis. This presents a challenge for clinicians at pre-
scribing review because they are required to make a deci-
sion about the need for ongoing antimicrobial treatment
without a microbiological diagnosis, using clinical assess-
ment and investigations.
Fig. 1 The use of parenteral antibiotics and blood cultures in patients attending the Emergency Department
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Whilst the majority of clinicians acknowledge that anti-
microbials are overused in hospital, it is extremely challen-
ging to change prescribing behaviour in the absence of
sensitive and specific diagnostic tests that can reliably rule
out bacterial infection. More than half of the antibiotics
prescribed to patients in this study were broad spectrum,
despite increasing evidence that broad-spectrum pres-
cribing is associated with selection of antimicrobial resist-
ance bacteria, including selection of extended-spectrum
beta-lactamase (ESBL) producing gram-negative bacteria
and Methicillin-resistant Staphylococcus aureus (MRSA)
[12, 13]. In a recent review [14], four heterogeneous stud-
ies of interventions involving prescribing review all dem-
onstrated a substantial improvement in prescribing quality
[15–18]. However, only two of these studies focused on
discontinuation of unnecessary antibiotics, either by in-
creasing the role of infectious disease specialists to scru-
tinise antimicrobial prescribing [15], or by introducing a
clinical scoring system to reduce unnecessary antibiotic
use [16]. Clinical decision support systems can improve
prescribing quality [19], but have yet to make a substantial
impact on total antimicrobial use [20], whereas introdu-
cing pro-calcitonin to improve diagnostic accuracy for
bacterial infection has been demonstrated to reduce the
duration of antibiotic treatment in secondary care [21].
The strength of this study is that is reflects real clinical
practice because QEHB is a paperless hospital and all
patient activity is recorded electronically. The limitations
are that our results may not be generalizable to other
sites, particularly because QEHB has a unique informat-
ics infrastructure. We analysed patient records at aggre-
gate rather than individual-level, and were therefore
unable to investigate clinical outcome in detail. We also
restricted our analysis to prescriptions for parenteral an-
timicrobials, although the impact of excluding oral anti-
microbials is likely to be small because patients who are
unwell enough to be admitted to hospital are frequently
commenced on parenteral antimicrobials. We only con-
sidered blood cultures and did not include other types of
microbial samples.
Conclusion
In patients admitted via the Emergency Department,
blood cultures may have a limited role in the diagnosis
of bacterial infection. Decisions to review antimicrobial
prescribing should combine clinical assessment with a
Fig. 2 Use of blood cultures and parenteral antibiotics within the 48 h following hospital admission, by age and gender, 2014
Table 1 Organism growth from blood cultures sampled from
patients admitted to UHB in 2014
Organism Number of patients (%)
E. coli 78 (27.7)
Coagulase negative Staphylococcus 44 (15.6)
Staphylococcus aureus 21 (7.4)
Klebsiella pneumonia 10 (3.5)
Streptococcus pneumonia 13 (4.6)
Beta haemolytic streptococcus group A 6 (2.1)
Proteus mirabilis 8 (2.8)
Corynebacterium sp. 7 (2.5)
Other 95 (33.7)
Total 282 (100)
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range of diagnostic information which includes, but is
not limited to, culture-based microbiology.
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